Loveworld Medical Centre Hosts International Symposium to Advance Precision Cancer Care in Africa

The growing potential of radiotheranostics—the integration of advanced imaging and targeted radioactive therapies—to provide more personalised cancer treat

Leading experts in nuclear medicine, oncology, radiopharmaceutical therapy, molecular imaging and precision medicine have converged at Loveworld Medical Centre, Lagos, for the 2026 International Symposium on Radiopharmaceutical Therapy (ISRT 2026). The two-day symposium, which commenced on Friday, August 28th, is themed “𝗔𝗱𝘃𝗮𝗻𝗰𝗶𝗻𝗴 𝗥𝗮𝗱𝗶𝗼𝘁𝗵𝗲𝗿𝗮𝗻𝗼𝘀𝘁𝗶𝗰𝘀 𝗮𝗻𝗱 𝗣𝗿𝗲𝗰𝗶𝘀𝗶𝗼𝗻 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗶𝗻 𝗔𝗳𝗿𝗶𝗰𝗮” and Day 1 of the program brought together medical professionals from Nigeria and countries including South Africa, Algeria, Egypt, Kenya, Ethiopia, Germany, India and the United States to explore emerging approaches to cancer diagnosis and treatment.

The symposium, organized by Loveworld Medical Centre in collaboration with the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH), International Centers for Precision Oncology (ICPO) Foundation and Chris Oyakhilome Foundation International (COFI), featured keynote presentations, plenary sessions, hands-on workshops and clinical case discussions.

Participants were examining developments in radiopharmaceutical therapy, molecular imaging, radioligand therapy and precision oncology, with particular attention to how these innovations can be adapted to strengthen cancer care and specialist capacity across Africa.

Speaking at the event, Pastor Deola Philips, Executive Minister, Ministry of Healing, Healthcare and Medical Services, and Chairman of Loveworld Medical Centre, emphasized the importance of building African expertise rather than relying solely on medical knowledge developed elsewhere. She noted that more than 120 participants had registered for the symposium, which was offered free of charge to promote wider access to specialist education.

Masha Maharaj, Director of Operations at Loveworld Medical Centre and President-elect of WARMTH, also highlighted the centre's experience with Actinium-based radiopharmaceutical therapy, which has been used in treating patients with cancers including breast cancer, sarcoma and lung cancer.

The symposium underscores the growing potential of radiotheranostics—the integration of advanced imaging and targeted radioactive therapies—to provide more personalised cancer treatment. With Loveworld Medical Centre already developing capacity in nuclear medicine and radiopharmaceutical therapy, the gathering provides an important platform for knowledge exchange, professional development and international collaboration.

Discussions are expected to further explore training, research, technology transfer and infrastructure needed to expand access to precision cancer care and strengthen Africa's role in the future of oncology.